Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
BadThe stock is in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
—
—
—
Wanbury Limited is a pharmaceutical company which offers active pharmaceutical ingredient in over 70 countries.
Customise key metrics, see detailed forecasts, download stock data and more
A significant proportion of promoter holdings is pledged
In last 3 months, mutual fund holding of the company has almost stayed constant
1 month ago•Moneycontrol
Wanbury Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download
Wanbury Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download
Wanbury Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 27, 2023. Further, the company has informed the Exchange regarding voting results. | Download
Wanbury Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 27, 2023. Further, the company has informed the Exchange regarding voting results. | Download
Final • Div/Share: ₹ 1
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant